MentiNova Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

MentiNova General Information

Description

Developer of drugs designed to treat Parkinson's disease. The company's drugs offer treatment for the neurodegenerative disorder and mental diseases, enabling healthcare providers to treat their patients and improve their lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 155 Village Boulevard
  • Suite 130
  • Princeton, NJ 08540
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MentiNova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 17-Nov-2020 00000 Completed Out of Business
1. Seed Round 25-Jan-2013 00000 00000 Completed Generating Revenue
To view MentiNova’s complete valuation and funding history, request access »